LILRB4 and Miyoshi myopathy: To further reveal how LILRB4 fine-tunes the tumorigenesis and metabolic profiles of MM cells, we evaluated several signaling pathways markedly changed in LILRB4-knockdown MM cells according to the RNA-seq data, such as the JAK-STAT signaling pathway and PI3K-AKT signaling pathway.